Myeloma Propagating Cells, Drug Resistance and Relapse.

about

Inhibition of HIF1α-Dependent Upregulation of Phospho-l-Plastin Resensitizes Multiple Myeloma Cells to Frontline Therapy.

P2860

Q55642634-52F0F4AB-3B2A-4CAC-90F2-C5D1053D1A11

P2860

Myeloma Propagating Cells, Drug Resistance and Relapse.

Item

http://www.wikidata.org/entity/Q38572771

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Myeloma Propagating Cells, Drug Resistance and Relapse.

@en

type

Item

label

Myeloma Propagating Cells, Drug Resistance and Relapse.

@en

prefLabel

Myeloma Propagating Cells, Drug Resistance and Relapse.

@en

P1476

Myeloma Propagating Cells, Drug Resistance and Relapse.

@en

P2093

Anastasios Karadimitris

http://www.w3.org/2001/XMLSchema#string

Aristeidis Chaidos

http://www.w3.org/2001/XMLSchema#string

Kanagaraju Ponnusamy

http://www.w3.org/2001/XMLSchema#string

Katerina Goudevenou

http://www.w3.org/2001/XMLSchema#string

Valentina Caputo

http://www.w3.org/2001/XMLSchema#string

Xiaolin Xiao

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of clonogenic multiple myeloma cells

Initial genome sequencing and analysis of multiple myeloma

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Discovery and saturation analysis of cancer genes across 21 tumour types

Clonal evolution in cancer

Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma.

Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells.

Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells.

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.

P304

3205-3211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/STEM.2199

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26302895

http://www.w3.org/2001/XMLSchema#string

Myeloma Propagating Cells, Drug Resistance and Relapse.

about

P2860

P2860

Myeloma Propagating Cells, Drug Resistance and Relapse.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698